The Drug-Induced Respiratory Disease Website
In addition to and other than PCP. Under construction. See also under XIe
Publications
Digging into the Histology.
The New England journal of medicine 2023 Oct 05;389;1321-1326 — 2023 Oct 05 — 1321-1326
Atypical presentation of pneumonia in a patient with rheumatoid arthritis treated with tofacitinib: a case presentation.
BMC rheumatology 2018;2;34 — 2018 — 34
Sandborn WJ, Su C, Sands BE, D'Haens GR, Vermeire S, Schreiber S, Danese S, Feagan BG, Reinisch W, Niezychowski W, Friedman G, Lawendy N, Yu D, Woodworth D, Mukherjee A, Zhang H, Healey P, Panés J,
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis.
The New England journal of medicine 2017 May 04;376;1723-1736 — 2017 May 04 — 1723-1736
Pulmonary Cryptococcosis in the Setting of Tofacitinib Therapy for Psoriasis.
Journal of drugs in dermatology : JDD 2015 Aug;14;901-2 — 2015 Aug — 901-2
van Vollenhoven RF, Fleischmann R, Cohen S, Lee EB, García Meijide JA, Wagner S, Forejtova S, Zwillich SH, Gruben D, Koncz T, Wallenstein GV, Krishnaswami S, Bradley JD, Wilkinson B,
Tofacitinib or adalimumab versus placebo in rheumatoid arthritis.
The New England journal of medicine 2012 Aug 09;367;508-19 — 2012 Aug 09 — 508-19
Fleischmann R, Kremer J, Cush J, Schulze-Koops H, Connell CA, Bradley JD, Gruben D, Wallenstein GV, Zwillich SH, Kanik KS,
Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis.
The New England journal of medicine 2012 Aug 09;367;495-507 — 2012 Aug 09 — 495-507
Vincenti F, Tedesco Silva H, Busque S, O'Connell P, Friedewald J, Cibrik D, Budde K, Yoshida A, Cohney S, Weimar W, Kim YS, Lawendy N, Lan SP, Kudlacz E, Krishnaswami S, Chan G
Randomized phase 2b trial of tofacitinib (CP-690,550) in de novo kidney transplant patients: efficacy, renal function and safety at 1 year.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2012 Sep;12;2446-56 — 2012 Sep — 2446-56